2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$15.93+$0.010 (+0.06%)
Price as of Jun 23, 2026 7:03 PM EDT- $524.0MMarket Cap
- 47.96%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$15.93+$0.010 (+0.06%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.92 | ||
Change | +$0.55 (+3.58%) | ||
Open | $15.32 | ||
High | $16.09 | ||
Low | $15.32 | ||
Previous Close | $15.37 | ||
Volume | 250,887 | ||
30-Day Average Volume | 146,825 | ||
1-Week Change | 5.99% | ||
1-Month Change | -5.91% | ||
1-Year Change | 47.96% | ||
3-Year Change | 255.36% | ||
5-Year Change | -35.96% | ||
Fundamentals | |||
Shares Outstanding | 34.1M | ||
Total Assets | $98.9M | ||
Market Cap | $524.0M | ||
Enterprise Value | $568.3M | ||
Period: QTR TTM FY | |||
Revenue | $22.1M | ||
Net Income | -$6.7M | ||
Free Cash Flow | -$6.0M | ||
EBIT | -$5.2M | ||
EBITDA | -$5.1M | ||
Net Working Capital | $70.8M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -111 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 36 | ||
P/E | -77 | ||
PEG | 1 | ||
Price/Free Cash Flow | -87 | ||
Price/Operating Cash Flow | -89 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue